← All journal entries

Happy Mold vs Angry Mold Part II: Testing and Binders

Mold in a water-damaged home, mold spores under the microscope, a urine test sample and lab results, and binders carrying mycotoxins out through the liver, bile and gut
Contents
  1. Mycotoxin Testing: Identifying Your Exposure
  2. Urinary Mycotoxin Panels
  3. Mycotoxin Antibody Testing
  4. Interpreting Test Results
  5. Nasal Cultures: When the Sinuses Become a Reservoir
  6. CIRS Markers: How the Body Is Reacting
  7. Environmental Testing
  8. Therapeutic Approaches: The Role of Binders
  9. Understanding Mycotoxin Binders
  10. Binder Selection Guide
  11. Important Binder Considerations
  12. Addressing Actinomycetes and Endotoxins
  13. Putting the Pieces Together
  14. The Critical Role of Mineral Balance in Recovery
  15. How Mycotoxins Disrupt Mineral Balance
  16. Critical Minerals for Recovery
  17. Other Important Minerals
  18. Timing Matters: Minerals and Toxin Burden
  19. Testing and Repletion Protocol
  20. Conclusion: The Layers of Recovery
  21. Final Thoughts
  22. Selected references and further reading

 

This is Part II of my mycotoxin series. If you haven't read Part I yet, start there to understand what mycotoxins are, how they damage your body, and why exposure is escalating in modern society.

In Part I, I explored the hidden threat of mycotoxins—how these toxic compounds enter your body, the devastating cellular damage they cause, and why some people are more susceptible than others. Now, let's turn to practical solutions: how to identify your exposure and support your body's recovery.

Mycotoxin Testing: Identifying Your Exposure

Urinary Mycotoxin Panels

The most practical way to assess personal mycotoxin burden is through urine testing. Modern mycotoxin panels can detect and quantify multiple mycotoxins simultaneously, providing valuable information about:

  • Which mycotoxins are being excreted (indicating recent or ongoing exposure)
  • Relative levels to guide treatment priorities

Common mycotoxins assessed in comprehensive panels include:

  • Ochratoxin A
  • Aflatoxins (B1, B2, G1, G2, M1)
  • Trichothecenes (T-2, HT-2, DON, others)
  • Macrocyclic trichothecenes (satratoxins, verrucarins, roridins)
  • Zearalenone
  • Fumonisins
  • Citrinin
  • Gliotoxin
  • Mycophenolic acid
  • Patulin
  • Sterigmatocystin
  • Chaetoglobosin A
  • Enniatin B

Understanding which mycotoxins are present helps guide treatment because different binders have varying affinities for specific mycotoxins, and different tools support the elimination of different mycotoxins from the body.

Mycotoxin Antibody Testing

Alongside the urine panel, I now also use antibody testing (MyMycoLab), which measures the immune system's antibody response to specific molds and mycotoxins. The two tests answer different questions: the urine panel shows what the body is actively clearing, while the antibody panel shows what the immune system has been exposed to and is reacting to.

Both have blind spots:

  • Urine testing can under-report when the body's elimination pathways are congested. Toxins that aren't moving out won't show up in urine, even when the load is high.
  • Antibody testing can under-report when the immune response is suppressed, and many mycotoxins are themselves immune-suppressing, so a weak antibody result doesn't always mean low exposure.

Run together, they cover each other's gaps. In my experience, pairing the two gives a much clearer impression of someone's true mycotoxin load than either test alone. An IgE response on the antibody panel tends to reflect a more recent exposure (Dr. Neil Nathan).

Interpreting Test Results

Several factors affect mycotoxin test interpretation:

Excretion Variability: People with impaired detoxification may show lower urinary levels despite high body burden. Their bodies aren't efficiently eliminating the toxins, so less appears in urine—paradoxically, low levels might indicate poor elimination rather than low exposure.

Half-Life Differences: Ochratoxin A, which binds tightly to albumin, persists in the body with a half-life of approximately 35 days (measured in a single volunteer). In contrast, trichothecenes have much shorter half-lives. This means OTA will show up on testing long after exposure, while trichothecenes may only appear if exposure occurred within days of testing. Mycotoxins can be stored in adipose tissue for a very long period of time, and I often see increased levels of mycotoxin excretion once the detoxification pathways open up.

Timing Considerations: For short-half-life mycotoxins, timing is critical. You might have significant exposure but test negative if enough time has passed for elimination.

Kidney Function: Impaired renal function affects excretion patterns. If kidneys aren't working optimally, mycotoxin elimination through urine will be compromised.

Provocation Protocols: Some practitioners use binders or other agents to mobilize stored mycotoxins before testing, which can reveal hidden body burdens that wouldn't otherwise show up in urine.

The "Tip of the Iceberg": A low first result in someone who is very sick often reflects poor excretion rather than a low load. Dr. Nathan finds the second test comes back higher about 80% of the time once elimination improves. If someone is feeling better on their program and their numbers rise, that usually means detox is working; if they're feeling worse, look for re-exposure or a program that is too aggressive.

Retest Every 3–4 Months: Levels bounce from week to week, so the trend matters more than any single result. Use first-morning urine, watch for dilute samples, and don't compare results between labs that use different methods (ELISA and mass spectrometry measure differently).

Knowing When to Stop: Once the urine panel is clear, Dr. Nathan continues treatment for about three more months, because around 20% of people relapse if treatment stops at the first clear test.

Nasal Cultures: When the Sinuses Become a Reservoir

The sinuses are warm, dark and moist, and every breath brings in new spores. When the air we breathe is full of mold, some of it can settle in and colonize the sinus lining. Once that happens, the sinuses become an internal source of exposure: the mold keeps producing mycotoxins inside us, even after we have left the building that made us sick. Fungi can be found in the sinuses of most people with chronic sinus inflammation, and naso-sinus fungal biofilms have been proposed as one reason some people with mold illness don't recover once the exposure is gone. Fungi from the sinuses can also be swallowed and seed the gut, which is one reason gut colonization can keep coming back.

Mold rarely lives there alone. It builds a biofilm, a protective slime that shelters microbes from the immune system, and it often shares that biofilm with bacteria. The one practitioners watch most closely is MARCoNS (multiple antibiotic-resistant coagulase-negative staphylococci). MARCoNS is associated with low levels of MSH, one of the regulatory hormones described below, and recent data suggest that clearing it goes along with higher MSH. MSH also has antimicrobial and antifungal properties of its own, which I explain in Neuroinflammation.

A nasal culture, a swab taken from deep in the nasal passage, can show:

  • Which molds are growing, which can be compared with the urine and antibody panels and with environmental testing
  • Whether MARCoNS or other bacteria are present, and what they are sensitive to
  • How much biofilm there is, which shows how well protected the colony is

During our new-home mold experience, my own nasal culture came back positive for MARCoNS and the mold Penicillium, along with strong biofilm, which fit the sinus symptoms and brain fog I was living with.

Timing matters. Gentle support for the sinus lining can start early, but breaking down biofilm and addressing the colonizing organisms comes later, once the exposure is removed, the nervous system and mast cells are calmer, drainage is open and binders are well established. Disturbing a biofilm releases what it has been holding, and mold under attack makes more mycotoxins to defend itself, so a body that isn't ready can react strongly. A common clue that biofilm is part of the picture: someone feels great on their program but can't wean off it, or their symptoms return as soon as they try. From there, the work goes in phases: supporting the sinus lining and drainage, breaking down the biofilm, and then addressing the organisms living in it.

CIRS Markers: How the Body Is Reacting

Urine and antibody panels show which toxins are present and what the immune system has met. They don't show how strongly the body is reacting. That is where the CIRS markers come in. CIRS (chronic inflammatory response syndrome) describes what happens when someone can't efficiently clear the biotoxins from a water-damaged building. The HLA-DR genes were long used to explain who this happens to, but they appear to play less of a role than once thought, as I explain in Part I. In CIRS, the innate immune system stays switched on long after the exposure, and inflammation spreads through many systems at once.

The markers most often used come from Dr. Ritchie Shoemaker's work:

  • TGF-β1: often elevated; it drives tissue remodeling, including in the airways, and can disturb immune regulation
  • C4a: a complement protein that tends to rise quickly after re-exposure, which makes it useful for tracking whether an environment is still a problem
  • MMP-9: an enzyme that rises with inflammation and helps inflammatory compounds move from the blood into tissues, including the brain
  • MSH (alpha-melanocyte-stimulating hormone): often low; it calms inflammation and supports sleep, pain control and the gut and skin barriers
  • VIP (vasoactive intestinal peptide): often low; it regulates inflammation and blood flow, especially in the lungs
  • ADH and osmolality: when the hormone that helps us hold on to water is out of balance, it can show up as excessive thirst and frequent urination
  • VEGF: can be low or high; when low, it affects blood flow and oxygen delivery to tissues and contributes to fatigue and poor exercise tolerance

Visual contrast sensitivity (VCS) is a simple screening test, done online in a few minutes, that measures how well the eyes pick out low-contrast patterns. Biotoxin illness often reduces it, and it tends to improve as people recover, which makes it an easy way to follow progress. A failed VCS doesn't prove mold illness, and a passed one doesn't rule it out. Some practitioners also use NeuroQuant, a volumetric brain MRI, which in Shoemaker's research showed a characteristic pattern of changes in specific brain regions in people with CIRS.

These markers aren't specific to mold: infections, other biotoxins and other inflammatory conditions can move them too. Where they help most is in showing the body's response and following it over time. Falling C4a and TGF-β1, rising MSH and an improving VCS suggest recovery is on track, while a sudden jump points back to the environment.

Environmental Testing

While urinary testing reveals body burden, environmental testing can help identify exposure sources:

Environmental Relative Moldiness Index (ERMI): A DNA-based test that analyzes dust samples for 36 different mold species, creating a score that indicates the moldiness of an environment.

HERTSMI-2: A simplified version of ERMI focusing on the five most problematic mold species commonly found in water-damaged buildings.

Mycotoxin Testing of Materials: Direct testing of building materials, dust, or air samples for mycotoxins (not just mold spores).

Settle Plates First: Mold spores are heavy and settle on the floor, so testing what settles adds an important view alongside air sampling. Dr. Nathan starts with settle plates left open on the floor for a couple of hours, then runs an ERMI in any room that grows mold.

Reading HERTSMI-2: By Dr. Ritchie Shoemaker’s cut-offs, scores over 15 are considered too high for someone who is ill to occupy the building; 11–15 is borderline; under 11 is considered safe.

Actinomycetes and Endotoxin Testing: Building dust can also be tested for actinomycetes and for endotoxin (an LAL assay). Dr. Jill Crista finds that people with CIRS don't do well when the endotoxin count is over 100, and she considers a count over 200 a sick building.

Look Beyond the Home: Workplaces, schools, churches, cars and devices such as CPAP machines can all be the source. A strong clue is feeling better within hours of leaving a building. Retest after remediation, and test any home someone plans to move into.

Important Note: The presence of mold in the environment doesn't necessarily correlate with individual body burden. Some people efficiently eliminate mycotoxins while others accumulate them. Environmental testing identifies sources; urine and antibody testing, correlated with history and symptoms, reveal personal impact.

Therapeutic Approaches: The Role of Binders

Successfully addressing mycotoxin illness rests on two things: eliminating the source of exposure and using appropriate mycotoxin binders. The source is the whole ecosystem of a damp building: the mold, the bacteria that grow alongside it, and everything both release. No amount of supplementation can overcome ongoing exposure, so if you're still living or working in a moldy environment, that comes first. Internal fungal colonization matters too, but it is addressed once binders are well established.

Once sources are identified and remediated, strategic use of binders becomes foundational to recovery.

Understanding Mycotoxin Binders

Mycotoxin binders work by binding to mycotoxins in the gastrointestinal tract, preventing their absorption and reabsorption through enterohepatic recirculation. When mycotoxins are processed by the liver and secreted into bile, they would normally be reabsorbed in the intestines—creating a recycling problem. Binders interrupt this cycle by capturing mycotoxins in the gut and facilitating their elimination through stool.

Different binders have varying affinities for specific mycotoxins, making proper selection based on testing results crucial.

Binder Selection Guide

This guide follows what the clinicians I learn from use in practice: Dr. Neil Nathan, Dr. Jill Crista and Beth O’Hara. A tick means at least one of them uses that binder for that mycotoxin. Two further binders follow, with what the research shows for each.

BinderAflatoxinsOchratoxin ATrichothecenesGliotoxinZearalenone
Activated charcoal✓✓✓
Dr. Nathan and Beth O’Hara. Broad and non-selective, so it is taken away from food and supplements. As Dr. Nathan puts it, charcoal does not truly bind: toxins cling to it, “more like static cling”
Bentonite clay✓✓✓✓✓
Dr. Nathan and Beth O’Hara, who finds it covers most mycotoxins and may be the stronger choice for ochratoxin
Chlorella✓✓
Dr. Nathan. Beth O’Hara uses only indoor-grown chlorella, because outdoor-grown can contain mercury
Humic and fulvic acids✓✓
Dr. Nathan
Glucomannan✓✓
Dr. Nathan
Saccharomyces boulardii✓debated
Dr. Nathan and Beth O’Hara use it for gliotoxin and for zearalenone. Dr. Crista avoids Saccharomyces yeasts with zearalenone, because they can convert it into a more estrogenic form. Unlike most binders, it can be taken with food
Insoluble fiber (rice bran, finely ground dried okra)✓✓✓✓
Dr. Crista’s natural alternative for toxins that leave through the bile; taken with food
Aloe✓
Dr. Crista, who uses it for gliotoxin because it also calms mast cells
Zeolite (clinoptilolite)✓
Beth O’Hara adds zeolite once charcoal and clay are established. In an animal study, clinoptilolite reduced the liver damage caused by aflatoxin (Ortatatli et al., 2005), and a modified zeolite lowered ochratoxin A residues (Vasiljević et al., 2021)
Modified citrus pectin (MCP)gentle adjunct
Not yet studied against mycotoxins. In a small pilot study it increased the urinary excretion of arsenic, cadmium and lead (Eliaz et al., 2006)

Ochratoxin A has a long half-life because it binds to albumin. Dr. Crista’s rule is “bioflavonoids before binders”: flavonoids free ochratoxin from albumin in the blood so that it can be cleared, and binders then catch it in the gut.

Enniatin B and chaetoglobosin have no binder research behind them yet. Dr. Nathan uses bentonite clay and Saccharomyces boulardii for enniatin B, and reports clearing chaetoglobosin with charcoal, clay and chlorella together.

One at a time: Beth O’Hara rarely sees anyone clear mycotoxins with only one or two binders, but how they are introduced matters. Dr. Nathan starts with whichever binder is likely to be gentlest, and Emily Givler adds binders one at a time, because with a combination product there is no way to tell which ingredient caused a reaction.

Important Binder Considerations

Timing and Administration

Proper timing is crucial for binder effectiveness:

  • Take binders away from food and medications: Wait at least 2 hours before or after eating, supplements, or medications. Binders are non-selective—they'll bind nutrients and medications along with toxins.
  • Start low, go slow: Begin with lower doses and gradually increase to assess tolerance. Some people experience a flare of symptoms as mycotoxins are mobilized. For zeolite, it’s actually often the opposite, what is called a 'reverse titration': start high, then decrease the dose slowly.
  • Consistency matters: Regular, consistent dosing maintains binding capacity throughout the day
  • Cycling or rotation: Some practitioners recommend cycling different binders or taking periodic breaks to prevent the body from adapting

Nutrient Considerations

Long-term binder use can affect nutrient status:

  • Mineral depletion risk: Some binders can bind essential minerals like calcium, magnesium, zinc, and iron and this needs to be considered.
  • Fat-soluble vitamin binding: Some binders also bind vitamins A, D, E and K, so these are worth watching during longer binder programs
  • Monitor and supplement: Regular nutrient testing and strategic supplementation (taken away from binders) helps prevent deficiencies
  • Timing is everything: Keep supplements and binders well apart; many people find it easiest to take them at opposite ends of the day

Hydration Requirements

Adequate water with electrolyte intake is essential:

  • Prevents constipation: Binders can be constipating, and constipation allows toxin reabsorption
  • Supports elimination: Water helps transport bound toxins through the GI tract
  • General guideline: Aim for about half your body weight (in pounds) in ounces of water daily, more if using multiple binders
  • Electrolyte balance: Consider electrolyte supplementation with high water intake

Individual Response and Adjustment

Everyone responds differently to binders:

  • Constipation: If this occurs, reduce dose, increase water/fiber, increase magnesium or try a different binder
  • Loose stools: May need to reduce dose or change binder type
  • Headaches or "herxing": May indicate too-rapid mobilization; slow down the detox process
  • No response: Might need a different binder type, higher dose, or to address upstream issues

Addressing Actinomycetes and Endotoxins

Dr. Jill Crista's approach starts with avoiding "bugophobia": the goal is not to scrub or sterilize, but to restore a healthy skin pH and healthy microbiomes. For endotoxins, her framework is bind, block and digest:

  • Bind: Chinese sarsaparilla (Smilax), serum-derived immunoglobulins and lactoferrin
  • Block: mixed bioflavonoids such as quercetin, which reduce LPS absorption
  • Digest: ox bile with bitters, since endotoxins suppress bile flow
  • Then rebalance: butyrate-rich foods, fermented foods once tolerated, and whole-plant berberine-containing herbs

For actinomycetes, she adds:

  • Address any active infection first (she favors usnea, which is also antifungal), then work on biofilms in phases
  • "A for actinos": vitamin A with monitoring, alongside omega-3s rich in DHA
  • Skin support: dry brushing, and sauna followed by a short cool rinse
  • Home: keep drain traps from drying out and clean them regularly with vinegar, remove houseplants whose soil has "turned", clean or replace water-holding devices (CPAP machines, humidifiers, water flossers). Dr. Crista aims for around 55% humidity to keep the airways moist; my own preference is to keep indoor humidity under 50%

Putting the Pieces Together

There is no single order that fits everyone. Where to begin depends on the person: how sensitive they are, what testing shows, and what their body can handle right now. I show how these layers fit together, as a map rather than a fixed order, on my approach page. These are the pieces that usually need to be in place, along with a few timing principles that hold for most people:

  • Eliminate exposure sources: Environmental remediation or relocation; begin sinus support if needed
  • Calm the nervous system and mast cells: Dr. Nathan estimates that about 90% of people with mold illness develop limbic and vagal dysfunction if left untreated, and 70–80% develop mast cell activation. In very sensitive people he does about six weeks of limbic and vagal work first, then mast cell support, before starting mold treatment; less sensitive people can do these alongside the other pieces
  • Support drainage pathways: Ensure bowels, kidneys, lymphatics, and liver are functioning before pushing detoxification. Dr. Marie Matheson separates three things: detox (the liver's chemistry), depuration (moving toxins out through sweat, stool and urine) and drainage (clearing the spaces between cells). Bowels come first, with a goal of one to three complete movements a day. Sauna can help: start with 5–10 minutes, wipe off the sweat, replace electrolytes and take a binder afterward
  • Implement binder therapy: Start with appropriate binders based on testing results
  • Support detoxification: Add liver support, glutathione, antioxidants. The exception is a high gliotoxin result, which usually points to Candida: Dr. Crista addresses the Candida before adding sulfur-based support such as glutathione and NAC, holding those off until antifungals are underway
  • Restore mineral balance: Foundational support can start early, with deeper repletion as toxin burden falls (see below)
  • Lower pathogenic load/fungal burden: Treat gut dysbiosis and fungal colonization. Have binders well established first, since starting antifungals (even gentle ones) before binders are on board can cause severe reactions
  • Heal damaged tissues: Address gut lining, mitochondrial function, neuroinflammation

Moving too fast—for instance, aggressively mobilizing toxins before drainage and binders are in place—can worsen symptoms and slow recovery.

The Critical Role of Mineral Balance in Recovery

One often-overlooked aspect of mycotoxin recovery is the profound impact these toxins have on mineral balance. The oxidative stress and mitochondrial dysfunction caused by mycotoxins disrupt normal mineral homeostasis throughout the body. Understanding and addressing mineral imbalances is crucial for recovery. Gentle foundational support can start early, with deeper repletion as toxin burden falls.

A critical insight: Mineral imbalances don't just affect cellular function—they directly correlate with hormonal imbalances. The zinc-copper imbalance nearly universal in mold illness drives estrogen dominance, worsens mast cell activation, and contributes significantly to neurological and psychiatric symptoms. As you'll see, correcting mineral imbalances often resolves hormonal symptoms without any direct hormone therapy.

How Mycotoxins Disrupt Mineral Balance

Increased Oxidative Stress Creates Mineral Demands

The excessive reactive oxygen species (ROS) generated by mycotoxin exposure dramatically increase the body's need for minerals that support antioxidant enzyme systems:

  • Copper and zinc: Required for superoxide dismutase (SOD), the first-line antioxidant enzyme that neutralizes superoxide radicals, collagen, detoxification, histamine degradation, neurotransmitter function/balance
  • Selenium: Essential cofactor for glutathione peroxidase, which neutralizes hydrogen peroxide and lipid peroxides, thyroid hormone enzymes
  • Manganese: Needed for mitochondrial manganese-SOD, protecting mitochondria from oxidative damage, collagen synthesis, ammonia detoxification
  • Molybdenum: Needed for supporting enzymes involved in detoxification (sulfite oxidase, xanthine oxidase, aldehyde oxidase)
  • Iron: Component of catalase (another critical antioxidant enzyme) and mitochondrial cytochrome c, found in hemoglobin to carry oxygen, CYP450 detox phase I enzymes in the liver, required for the first step in dopamine and serotonin production

And for all of these minerals, so much more. The chronic oxidative assault from mycotoxins depletes these minerals and causes imbalances in them as the body desperately attempts to maintain antioxidant defenses.

Impaired Absorption

Mycotoxin-induced gut damage severely compromises mineral absorption:

  • Damaged enterocytes: The intestinal cells responsible for mineral transport are damaged or killed by mycotoxins
  • Tight junction disruption: Leaky gut alters the normal paracellular transport pathways
  • Inflammatory cytokines: Pro-inflammatory signals interfere with mineral transporter expression and function
  • Microbiome disruption: Beneficial bacteria that aid mineral absorption and produce vitamin K2 (important for calcium metabolism) are depleted

Increased Excretion

The stress response and kidney effects of mycotoxins increase mineral losses:

  • Stress hormones: Chronic cortisol elevation increases urinary excretion of magnesium, calcium, potassium and zinc
  • Kidney tubule damage: Some mycotoxins (particularly ochratoxin A) damage kidney tubules, impairing mineral reabsorption
  • Sweating during detoxification: Sauna therapy and other detox methods remove minerals along with toxins

Binders and Minerals

While binders are essential for mycotoxin removal, they present a challenge:

  • Non-selective binding: Some binders don't distinguish between toxins and beneficial minerals
  • Prolonged binder use: Extended protocols can create or worsen mineral deficiencies
  • The trade-off: The benefit of mycotoxin binding outweighs the mineral chelation risk, but monitoring and repletion become essential

Critical Minerals for Recovery

As source elimination, drainage and binders lower the mycotoxin burden, normalizing mineral status becomes a powerful tool for supporting the body's healing capacity.

Zinc: The Master Mineral

Zinc is involved in over 300 enzymatic reactions and is typically severely depleted in mycotoxin illness:

Functions critical for recovery:

  • Immune function: Required for T-cell development, natural killer cell activity, and cytokine signaling
  • Gut barrier integrity and digestion: Essential for tight junction protein expression and enterocyte turnover, necessary for stomach acid production
  • Antioxidant defense: Component of copper-zinc SOD; required for metallothionein synthesis (helps detoxify heavy metals often elevated in mold illness)
  • Wound healing: Critical for tissue repair and regeneration, collagen formation
  • Detoxification: Required for alcohol dehydrogenase and other Phase I enzymes
  • Neuronal Health: Required for BDNF (brain derived neurotrophic factor), NMDA receptor modulation, metallothionein induction to bind heavy metals and excess copper in the brain

Why zinc is depleted in mold illness:

  • Increased demand from oxidative stress and inflammation
  • Impaired absorption from gut damage
  • Increased losses from stress response
  • Competitive inhibition from copper elevation (often seen in mold illness)
  • Lack of dietary zinc (modern diets are zinc-poor)
  • Binding by phytates in grains and legumes (reduces zinc bioavailability)

The Zinc-Copper Seesaw: A Critical Imbalance

Zinc and copper exist in a delicate, reciprocal relationship. When one goes up, the other tends to go down. In mold illness, I very often see:

  • Zinc depletion (low levels on testing, often severe)
  • Hidden copper accumulation (revealed especially well on HTMA, not always obvious on serum testing)
  • Inverted or severely imbalanced zinc:copper ratios

This imbalance has profound consequences:

When zinc is low:

  • Copper absorption increases (they compete for the same intestinal transporters)
  • Metallothionein production drops (zinc stimulates MT, which binds excess copper for excretion)
  • Copper accumulates in tissues because it can't be properly excreted - typically bile and liver detoxification is impaired which is copper's primary exit out of the body
  • The rising copper further displaces zinc from binding sites
  • A vicious cycle develops: low zinc → high copper → even lower zinc
  • The major storage sites of copper in the body are the liver and the brain

Why this matters beyond mineral balance:

As the copper section below explains, the zinc-copper imbalance directly correlates with hormonal imbalances:

  • Low zinc = reduced testosterone production and increased estrogen dominance
  • High copper = increased estrogen activity and receptor sensitivity
  • Together, they create a pronounced estrogen dominant state
  • This worsens mast cell activation (estrogen promotes degranulation)
  • Amplifies histamine intolerance and inflammatory symptoms
  • Contributes to mood disturbances, anxiety, and cognitive symptoms

The clinical presentation: A person with severe zinc depletion and hidden copper toxicity might present with:

  • Severe immune dysfunction and recurrent infections (low zinc)
  • Neurological symptoms and cognitive impairment (copper neurotoxicity)
  • Estrogen dominance symptoms (the mineral-hormone connection)
  • Poor wound healing (zinc deficiency)
  • Mast cell activation and histamine issues (estrogen + copper)
  • Anxiety, racing thoughts, and emotional dysregulation (copper excess, neurotransmitter disruption)

This is why HTMA testing is so valuable—it reveals the hidden copper that serum testing often misses, explaining symptoms that otherwise seem mysterious.

 

Copper: The Double-Edged Mineral

Copper requires careful attention in mold illness:

Critical functions:

  • Mitochondrial energy production: Component of cytochrome c oxidase (Complex IV of electron transport chain)
  • Antioxidant defense: Part of copper-zinc SOD; component of ceruloplasmin (a major antioxidant enzyme)
  • Iron metabolism: Ceruloplasmin oxidizes iron for proper transport and utilization
  • Neurotransmitter synthesis: Required for dopamine β-hydroxylase (converts dopamine to norepinephrine)
  • Connective tissue formation: Necessary for lysyl oxidase, which crosslinks collagen and elastin

The copper paradox in mold illness:

  • Copper is often elevated in serum but functionally deficient at the cellular level
  • Ceruloplasmin (the copper-carrying protein) may be low, indicating poor copper utilization
  • Oxidative stress can cause copper dysregulation, leading to both deficiency symptoms and toxicity symptoms simultaneously
  • Free, unbound copper is pro-oxidant and inflammatory

Why this matters for symptom presentation:

Women with mold illness often experience more severe symptoms during high-estrogen phases of their cycle because:

  1. The copper-zinc imbalance is creating estrogen dominance
  2. Mycotoxins like zearalenone add xenoestrogenic effects
  3. Inflamed adipose tissue increases aromatase activity
  4. This triple estrogen hit amplifies mast cell activation and histamine symptoms

Men with mold illness may develop estrogen dominance symptoms due to:

  1. Low zinc allowing excessive aromatization of testosterone to estrogen
  2. High hidden copper promoting estrogenic effects
  3. Mycotoxin-induced testosterone suppression
  4. The combination creating a "low T, high E" pattern

Testing approach:

  • Serum copper is best read together with ceruloplasmin and HTMA
  • HTMA (Hair Tissue Mineral Analysis) is key - it adds a tissue view of copper accumulation - analysis is complex work with an experienced practitioner
  • Calculate copper:ceruloplasmin ratio (high copper, low ceruloplasmin = unbound copper)
  • Micronutrient panel can evaluate intracellular copper and zinc levels
  • Zinc:copper ratio should ideally be 8:1 to 10:1 (often inverted in mold illness)
  • Consider testing sex hormones (estradiol, progesterone, testosterone, DHEA) alongside minerals to see the correlation

Supplementation considerations:

  • Most people with mold illness do not need copper supplementation initially - often people have hidden copper toxicity despite functional deficiency

The goal is usually to:

  1. Increase zinc (which promotes copper excretion by blocking absorption and balances the ratio)
  2. Support copper mobilization from tissues slowly with targeted micromineral interventions guided by HTMA
  3. Enhance copper excretion through bile, supporting liver/gallbladder health
  4. Support ceruloplasmin production by supporting adrenal function and hormonal balance
  • Only supplement copper if true deficiency is confirmed after addressing zinc deficiency and measuring ceruloplasmin
  • Prefer to use food sources such as grass-fed liver, shellfish, mushrooms before supplementation
  • Support ceruloplasmin production with adequate protein, vitamin A and vitamin C
  • If copper mobilization occurs too quickly, strong 'copper dump' symptoms may appear: supporting binding excess copper and stepping back from pushing its excretion is critical - slow and steady wins the race here

Monitor hormonal symptoms: As the zinc-copper ratio normalizes, many people see improvement in:

  • Estrogen dominance symptoms (lighter periods, reduced PMS, less breast tenderness)
  • Mast cell activation and histamine intolerance
  • Anxiety and emotional reactivity
  • Testosterone levels (in both men and women)
  • Libido and sexual function
  • Body composition (easier fat loss, better muscle development)

The mineral-hormone connection is so strong that practitioners often see hormonal symptoms resolve simply by correcting zinc-copper imbalance, without any direct hormone supplementation or therapy.

Magnesium: The Relaxation and Energy Mineral

Magnesium deficiency is nearly universal in chronic illness, and especially severe in mold illness:

Essential roles:

  • ATP production: Required for over 600 enzymatic reactions; every ATP molecule must be bound to magnesium to be biologically active
  • Mitochondrial function: Necessary for all five complexes of the electron transport chain
  • Glutathione synthesis: Required cofactor for both glutathione-making enzymes, including glutamate cysteine ligase, the rate-limiting step
  • Detoxification: Required for Phase I and Phase II detox enzyme function
  • Nervous system regulation: Blocks N-methyl-D-aspartate (NMDA) receptors, preventing excitotoxicity; regulates neurotransmitter release
  • Cellular membrane stability: Maintains proper ion gradients
  • Muscle, vascular and nerve function: Natural calcium channel blocker; prevents excessive cellular calcium influx, essentially keeps calcium out of arteries and in bone. When it’s low, calcium can accumulate in tissues

Why magnesium is critically depleted:

  • Chronic stress dramatically increases magnesium losses (cortisol causes renal magnesium wasting)
  • Inflammation increases magnesium utilization
  • Impaired gut absorption from mycotoxin damage
  • Increased demand from ATP depletion and cellular repair processes
  • Modern diet is generally magnesium-poor

Testing considerations:

  • Serum magnesium reflects only about 1% of body stores and is tightly regulated, so I read it alongside other measures
  • Micronutrient panels, such as the SpectraCell panel
  • HTMA can help identify loss or deficiency
  • Symptoms and clinical presentation guide supplementation alongside testing

Repletion strategies:

  • Amount: Individualized, guided by symptoms, bowel tolerance and HTMA
  • Forms: Magnesium glycinate (well-absorbed, calming), magnesium threonate (crosses blood-brain barrier), magnesium malate (energizing), magnesium taurate (cardiovascular support)
  • Avoid: Magnesium oxide (poorly absorbed, mainly acts as laxative)
  • Transdermal: Magnesium oil or Epsom salt baths can bypass gut absorption issues
  • Take away from binders: Separate by at least 2 hours
  • Divide doses: Better absorbed in divided doses throughout the day
  • Bowel tolerance: Reduce dose if loose stools develop

Calcium: The Signaling Mineral

While less commonly deficient than other minerals in mold illness, calcium balance is important:

Key functions:

  • Cellular signaling: Intracellular calcium acts as a second messenger for countless processes
  • Nerve transmission: Required for neurotransmitter release
  • Muscle contraction: Including heart muscle
  • Bone and teeth structure: Obvious but important
  • Blood clotting: Essential for coagulation cascade

Calcium considerations in mold illness:

  • Often not deficient in total body stores
  • Intracellular calcium may be elevated (calcium dysregulation contributes to mitochondrial dysfunction)
  • Ratio with magnesium is critical (ideal ratio 2:1 to 1:1 calcium:magnesium)
  • Focus on magnesium repletion first
  • Vitamin D3 and K2 are necessary for proper calcium metabolism
  • Often calcium is moved from bone into tissue, until balance is restored, supplementing with calcium can just drive more calcium into tissues, not bone

Testing and supplementation:

  • Serum calcium is tightly regulated, so it reflects blood levels rather than tissue status
  • HTMA helpful to look at Ca/Mg ratio and look for a calcium shell or depletion
  • Most people with mold illness need magnesium more than calcium supplementation
  • If supplementing: Use calcium citrate or microcrystalline hydroxyapatite (MCHA)
  • Always pair with magnesium and ensure adequate vitamin D3/K2

Other Important Minerals

Iron:

  • Can be either low or elevated in mold illness
  • Mycotoxins can disrupt iron metabolism
  • Anemia of chronic inflammation is common
  • Test: Complete iron panel (serum iron, ferritin, TIBC, transferrin saturation)
  • Supplement only if deficient; excess iron is pro-oxidant and can do more harm than good

Selenium:

  • Critical for glutathione peroxidase function
  • Often depleted in chronic illness
  • HTMA helps look at levels
  • Selenium has a narrow safe range, so the amount is individualized and more is not better

Manganese:

  • Required for mitochondrial SOD, collagen synthesis and ammonia detoxification
  • Less commonly supplemented but may be helpful
  • Food sources: nuts, whole grains, leafy greens
  • Supplement cautiously, and only when testing supports it

Timing Matters: Minerals and Toxin Burden

Minerals come in at more than one point, and the timing depends on the person:

Foundational support can start early

  • Gentle, foundational minerals, guided by HTMA, often begin alongside nervous system and drainage support
  • They help the body tolerate the rest of the work

Deeper repletion works best once exposure is controlled

  • While exposure continues, oxidative stress and inflammation keep depleting minerals
  • Drainage, binders, and liver and kidney support lower the burden

As toxin burden falls, minerals hold

  • The body can now hold onto and use supplemented minerals
  • Recovery often accelerates with proper mineral support

Why timing matters: Trying to fully normalize minerals while toxin burden remains high is inefficient—the ongoing oxidative stress and inflammation will continue depleting minerals faster than they can be repleted. It’s like trying to fill a bathtub with the drain open. However, once toxin burden is reduced through binders and detoxification support, mineral repletion becomes a powerful accelerator of healing.

Testing and Repletion Protocol

Comprehensive mineral panel:

  • Hair Tissue Mineral Analysis (HTMA) - important for copper assessment: HTMA shows long-term mineral patterns (representing 3-4 months of accumulation) and tissue storage, not just what's circulating in blood at the moment of testing.
  • Serum copper and ceruloplasmin together
  • Complete iron panel
  • Micronutrient panel

Repletion Strategies:

Work with a knowledgeable practitioner:

  • Mineral balancing is complex
  • Imbalances can create other imbalances
  • Ratios between minerals matter as much as absolute levels

Use highly bioavailable forms:

  • Glycinates, picolinates, chelates, and bisglycinate forms
  • Avoid oxide forms (poorly absorbed)
  • Consider liposomal formulations for even better absorption

Account for cofactors:

  • Minerals don't work in isolation
  • Vitamin D enhances calcium absorption, but needs Mg to become activated form
  • Vitamin C and A support copper utilization
  • B-vitamins support mineral-dependent enzymes

Monitor and retest:

  • Recheck levels every 2-3 months initially
  • Adjust supplementation based on results
  • Watch for signs of over-supplementation
  • Be vigilant for new imbalances created by repletion

Be patient:

  • Mineral repletion takes months, not weeks
  • Functional improvement often precedes lab normalization
  • Consistency is more important than aggressive dosing

Timing considerations:

  • Take minerals away from binders (at least 2 hours, except zeolite)
  • Calcium and magnesium compete; consider taking at different times
  • Zinc is best taken on empty stomach (or with food if nauseating)
  • Iron should be taken separately from calcium, magnesium, and zinc

Conclusion: The Layers of Recovery

Mycotoxin illness is complex, but recovery is possible with a systematic approach. These layers overlap, and the order depends on the person:

Assessment

  • Get comprehensive mycotoxin testing (urine and antibody panels) and functional work up (comprehensive gut analysis, HTMA, food sensitivities, toxin panel, OAT - organic acids test for fungal colonization, nasal culture, and CIRS markers with VCS when the picture calls for it)
  • Identify environmental sources (ERMI, HERTSMI-2, or direct mycotoxin testing)

Removing Exposure and Calming the Nervous System

  • Remove yourself from contaminated environments or remediate properly
  • Ensure the source of ongoing exposure is eliminated
  • Support the nervous system and mast cells with targeted interventions

Drainage, Binding and Detoxification

  • Support drainage pathways (bowels, kidneys, lymphatics)
  • Implement appropriate binders based on your specific mycotoxin profile
  • Provide comprehensive liver support
  • Support glutathione and antioxidant systems

Minerals, Gut and Brain Support

  • Normalize mineral balance (zinc, magnesium, copper, calcium, selenium)
  • Support gut lining and restore microbiome
  • Support mitochondrial recovery
  • Address neuroinflammation and brain healing

Addressing Colonization and Pathogens

  • Address fungal colonization in the sinuses and gut, and other pathogenic microorganisms, once binders are well established

Retesting and Resilience

  • Retest to confirm mycotoxin clearance and mineral normalization
  • Address any remaining symptoms
  • Implement lifestyle strategies to prevent re-exposure
  • Support long-term resilience and health

Final Thoughts

Recovery from mycotoxin illness requires patience, persistence, and a comprehensive approach. While the journey can be long, many people achieve significant improvement or full recovery with proper identification, remediation, detoxification, and mineral restoration.

The key insights to remember:

  1. You can't supplement your way out of ongoing exposure - source elimination is non-negotiable
  2. Binders are foundational - they interrupt the vicious cycle of mycotoxin recirculation
  3. Timing matters, but the order is personal - exposure control usually comes first, and drainage and binders need to be in place before anything that mobilizes toxins or targets organisms; beyond that, the order depends on you
  4. Everyone is different - genetics, hormones, toxic burden, and mineral status all influence your individual path
  5. Your body wants to heal - given the right tools and environment, recovery is possible

Selected references and further reading

Clinical teaching: Nathan N, Crista J, Matheson M.

Key studies and reviews behind the mechanisms described above. Many of the patterns in this article also come from clinical experience shared across practitioners, which doesn't always have a single paper behind it.

Testing: what urine and environmental tests show

  1. Hooper DG, Bolton VE, Guilford FT, Straus DC. Mycotoxin detection in human samples from patients exposed to environmental molds. Int J Mol Sci. 2009;10(4):1465-75. PubMed 19468319
  2. Brewer JH, Thrasher JD, Straus DC, Madison RA, Hooper D. Detection of mycotoxins in patients with chronic fatigue syndrome. Toxins (Basel). 2013;5(4):605-17. PubMed 23580077
  3. Studer-Rohr I, Schlatter J, Dietrich DR. Kinetic parameters and intraindividual fluctuations of ochratoxin A plasma levels in humans. Arch Toxicol. 2000;74(9):499-510. PubMed 11131029
  4. Vidal A, Claeys L, Mengelers M, Vanhoorne V, Vervaet C, Huybrechts B, et al. Humans significantly metabolize and excrete the mycotoxin deoxynivalenol and its modified form deoxynivalenol-3-glucoside within 24 hours. Sci Rep. 2018;8(1):5255. PubMed 29588479
  5. Vesper S, McKinstry C, Haugland R, Wymer L, Bradham K, Ashley P, et al. Development of an Environmental Relative Moldiness index for US homes. J Occup Environ Med. 2007;49(8):829-33. PubMed 17693779

Binders: how they work and what the evidence shows

  1. Egner PA, Wang JB, Zhu YR, Zhang BC, Wu Y, Zhang QN, et al. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc Natl Acad Sci U S A. 2001;98(25):14601-6. PubMed 11724948
  2. Wang P, Afriyie-Gyawu E, Tang Y, Johnson NM, Xu L, Tang L, et al. NovaSil clay intervention in Ghanaians at high risk for aflatoxicosis: II. Reduction in biomarkers of aflatoxin exposure in blood and urine. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2008;25(5):622-34. PubMed 18478481
  3. Avantaggiato G, Havenaar R, Visconti A. Evaluation of the intestinal absorption of deoxynivalenol and nivalenol by an in vitro gastrointestinal model, and the binding efficacy of activated carbon and other adsorbent materials. Food Chem Toxicol. 2004;42(5):817-24. PubMed 15046828
  4. Raj J, Vasiljević M, Tassis P, Farkaš H, Bošnjak-Neumüller J, Männer K. Effects of a modified clinoptilolite zeolite on growth performance, health status and detoxification of aflatoxin B1 and ochratoxin A in male broiler chickens. Br Poult Sci. 2021;62(4):601-10. PubMed 33595390
  5. Alassane-Kpembi I, Pinton P, Hupé JF, Neves M, Lippi Y, Combes S, et al. Saccharomyces cerevisiae Boulardii reduces the deoxynivalenol-induced alteration of the intestinal transcriptome. Toxins (Basel). 2018;10(5):E199. PubMed 29762474
  6. Poór M, Dombi Á, Fliszár-Nyúl E, Pedroni L, Dellafiora L. Effects of chrysin and chrysin-7-sulfate on ochratoxin A-albumin interactions and on the plasma and kidney levels of the mycotoxin in rats. ACS Omega. 2024;9(15):17655-66. PubMed 38645364

What mycotoxins do in the body

  1. Akbari P, Braber S, Varasteh S, Alizadeh A, Garssen J, Fink-Gremmels J. The intestinal barrier as an emerging target in the toxicological assessment of mycotoxins. Arch Toxicol. 2017;91(3):1007-29. PubMed 27417439
  2. Malir F, Ostry V, Pfohl-Leszkowicz A, Malir J, Toman J. Ochratoxin A: 50 years of research. Toxins (Basel). 2016;8(7):E191. PubMed 27384585
  3. Zinedine A, Soriano JM, Moltó JC, Mañes J. Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: an oestrogenic mycotoxin. Food Chem Toxicol. 2007;45(1):1-18. PubMed 17045381
  4. Zaitsu M, Narita S, Lambert KC, Grady JJ, Estes DM, Curran EM, et al. Estradiol activates mast cells via a non-genomic estrogen receptor-alpha and calcium influx. Mol Immunol. 2007;44(8):1977-85. PubMed 17084457

Minerals in recovery

  1. Brewer GJ. Zinc acetate for the treatment of Wilson's disease. Expert Opin Pharmacother. 2001;2(9):1473-7. PubMed 11585025
  2. Prasad AS. Zinc in human health: effect of zinc on immune cells. Mol Med. 2008;14(5-6):353-7. PubMed 18385818
  3. de Baaij JH, Hoenderop JG, Bindels RJ. Magnesium in man: implications for health and disease. Physiol Rev. 2015;95(1):1-46. PubMed 25540137
  4. Rayman MP. Selenium and human health. Lancet. 2012;379(9822):1256-68. PubMed 22381456

Sinus colonization and CIRS markers

  1. Ponikau JU, Sherris DA, Kern EB, Homburger HA, Frigas E, Gaffey TA, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc. 1999;74(9):877-84. PubMed 10488788
  2. Brewer JH, Thrasher JD, Hooper D. Chronic illness associated with mold and mycotoxins: is naso-sinus fungal biofilm the culprit? Toxins (Basel). 2013;6(1):66-80. PubMed 24368325
  3. DiTulio M, Navarro-Torres CA. Clearance of multiple antibiotic-resistant coagulase-negative staphylococci is selectively associated with higher circulating α-melanocyte stimulating hormone in patients evaluated for chronic inflammatory response syndrome. Front Endocrinol (Lausanne). 2026;17:1728408. PubMed 42077435
  4. Shoemaker RC, House DE. Sick building syndrome (SBS) and exposure to water-damaged buildings: time series study, clinical trial and mechanisms. Neurotoxicol Teratol. 2006;28(5):573-88. PubMed 17010568
  5. Hudnell HK. Chronic biotoxin-associated illness: multiple-system symptoms, a vision deficit, and effective treatment. Neurotoxicol Teratol. 2005;27(5):733-43. PubMed 16102938
  6. Shoemaker RC, House D, Ryan JC. Structural brain abnormalities in patients with inflammatory illness acquired following exposure to water-damaged buildings: a volumetric MRI study using NeuroQuant. Neurotoxicol Teratol. 2014;45:18-26. PubMed 24946038

Zeolite, pectin and fiber as binders

  1. Ortatatli M, Oğuz H, Hatipoğlu F, Karaman M. Evaluation of pathological changes in broilers during chronic aflatoxin (50 and 100 ppb) and clinoptilolite exposure. Res Vet Sci. 2005;78(1):61-68. PubMed 15500841
  2. Vasiljević M, Marinković D, Milićević D, Pleadin J, Stefanović S, Trialović S, et al. Efficacy of a Modified Clinoptilolite Based Adsorbent in Reducing Detrimental Effects of Ochratoxin A in Laying Hens. Toxins (Basel). 2021;13(7):469. PubMed 34357941
  3. Eliaz I, Hotchkiss AT, Fishman ML, Rode D. The effect of modified citrus pectin on urinary excretion of toxic elements. Phytother Res. 2006;20(10):859-864. PubMed 16835878